Celgene Corp. (CELG)

CELG (NASDAQ:Biotechnology) EQUITY
$79.49
pos +1.80
+2.40%
Today's Range: 78.51 - 79.89 | CELG Avg Daily Volume: 7,176,600
Last Update: 05/24/18 - 4:47 PM EDT
Volume: 8,483,578
YTD Performance: -25.58%
Open: $78.76
Previous Close: $77.66
52 Week Range: $74.13 - $147.17
Oustanding Shares: 724,827,000
Market Cap: 54,137,332,031
6-Month Chart
TheStreet Ratings Grade for CELG
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 14 15 15 16
Moderate Buy 1 0 0 0
Hold 12 13 13 12
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.93 1.93 1.93 1.86
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 21.34
Price Earnings Comparisons:
CELG Sector Avg. S&P 500
21.34 21.22 19.80
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-18.77% -33.80% -33.10%
GROWTH 12 Mo 3 Yr CAGR
Revenue 17.40 0.70 0.19
Net Income 46.69 0.50 0.14
EPS 46.19 0.50 0.15
Earnings for CELG:
EBITDA 3.65B
Revenue 12.82B
Average Earnings Estimates
Qtr (06/18) Qtr (09/18) FY (12/18) FY (12/19)
Average Estimate $1.87 $1.98 $7.63 $8.97
Number of Analysts 2 2 2 2
High Estimate $1.87 $1.99 $7.74 $9.07
Low Estimate $1.87 $1.96 $7.52 $8.86
Prior Year $1.68 $1.78 $6.84 $7.63
Growth Rate (Year over Year) 11.31% 10.96% 11.55% 17.50%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
RMPIA
By

Bret Jensen

 | May 4, 2018 | 9:02 AM EDT
The April Jobs report showed that 164,000 jobs were created last month. This is nearly 30,000 jobs less than the consensus. Unemployment rates tumbles to 3.9%, the first time under the 4% level in almost two decades.
RMPIA
By

Stephen Guilfoyle

 | May 4, 2018 | 7:50 AM EDT
The Chinese have something to lose here, and will not willingly surrender their position of superiority in trade.
RMPIA
By

Bret Jensen

 | May 4, 2018 | 6:59 AM EDT
It is good once again to be sitting in for Doug Kass on a Friday here on the Daily Diary. Going to be a busy day as we get the monthly jobs report coming out in just over an hour. Although GDP growth (2.3%) did slow in the first quarter from the 3% level it was running at during the previous three quarters, the economy is quite strong.
RMPIA
By

Bret Jensen

 | Apr 16, 2018 | 2:26 PM EDT
Data and industry conferences will likely be catalysts for shares in the space.
RMPIA
By

Bret Jensen

 | Apr 11, 2018 | 1:00 PM EDT
Novartis' deal for AveXis has ignited a rally in other gene-therapy concerns.
RMPIA
By

Bret Jensen

 | Apr 11, 2018 | 10:28 AM EDT
Now that M&A is picking up in the sector, here's what to watch as earnings releases begin to hit.
RMPIA
By

Bret Jensen

 | Apr 9, 2018 | 11:40 AM EDT
A look at possible second-quarter M&A activity in the biotech sector.
RMPIA
By

Bret Jensen

 | Mar 23, 2018 | 11:10 AM EDT
Markets continue to meander between being slightly up or slightly down as equities struggle for a direction after yesterday's big slide. New homes sales for the month of February were above expectations with the average selling price 10% above the same period a year ago. Sorry to report Miami business icon Wayne Huizenga has died today at the age of 80. He was the force behind the creation of Waste Management (WM)  and Autonation (AN)  and also owned the Miami Dolphins for some time as well.
RMPIA
By

Bruce Kamich

 | Mar 22, 2018 | 10:42 AM EDT
Let's check the charts.
RMPIA
By

Bret Jensen

 | Mar 17, 2018 | 2:00 PM EDT
Your burning biotech questions answered in our latest mailbag.
join me for a free webinar after the close today as we discuss some of those calendar ritu...
AAII Bulls ticked up this week to 38.6% which is the highest they have been since February...
I am on the ground in San Fran. to cover PayPal's (PYPL) big investor day today. Had a ch...
We are very close to a trigger for entry in BIDU against one of the standout zones discuss...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.